SCHEMBL6939460

SCHEMBL6939460

Cn1cc(CC[C@H](O)CO[Si](C)(C)C(C)(C)C)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.46
GPR84 Q9NQS5 1/20 0.43
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
SLC6A4 P31645 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
IDO1 P14902 1/20 0.39
TP53 P04637 3/20 0.38
LMNA P02545 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GRM2 Q14416 1/20 0.38
GRM3 Q14832 1/20 0.38
GLS O94925 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939466 1.00 HTR2A (0.46) HTR2AGPR84KDM4EHSD17B10HPGD
SCHEMBL6935381 0.82 ADA (0.46) KMT2AMEN1
SCHEMBL6935374 0.82 ADA (0.46) KMT2AMEN1
SCHEMBL6938178 0.79 TK1 (0.40) KDM4EHPGDSLC6A4KMT2AMEN1
SCHEMBL6938174 0.79 TK1 (0.40) KDM4EHPGDSLC6A4KMT2AMEN1
SCHEMBL6937603 0.77 HTR2A (0.58) HTR2AGPR84KDM4EHSD17B10HPGD
SCHEMBL6937592 0.77 HTR2A (0.58) HTR2AGPR84KDM4EHSD17B10HPGD
SCHEMBL6935332 0.77 ADA (0.57) HTR2AKDM4EHSD17B10HPGDKMT2A
SCHEMBL7836552 0.75 KDM4E (0.40) HTR2AKDM4EHSD17B10HPGDKMT2A
SCHEMBL6171832 0.74 DHFR (0.41) KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed